期刊文献+

环状RNA与心血管衰老及心血管病的研究进展 被引量:2

The research progress in circular RNA with cardiovascular aging and cardiovascular diseases
下载PDF
导出
摘要 环状RNA(circRNA)具有与线性RNA完全不同的共价闭环结构,在哺乳动物组织中普遍表达, 在心血管领域,circRNA已被证明具有抗心血管衰老、与RNA结合蛋白结合作为microRNA海绵、作为生物标志物及作为疾病治疗的靶点等多种功能。本文综述了近年来环状RNA与心血管衰老及circRNA在心血管病作用的研究进展。 CircRNA have covalent closed-loop structures completely different from linear RNA,which are widely expressed in mammalian tissues.In the field of cardiovascular diseases,circRNA have been proven to have anti-cardiovascular aging,combining with RNA binding proteins as microRNA sponges,serving as biomarkers and as targets for disease treatment,etc.This paper reviews the recent progress in the research on the role of circRNA in cardiovascular aging and diseases.
作者 凌浩 张艳秋 杨闯 肖钰 廉瑞 宋春莉 LING Hao;ZHANG Yan-qiu;]YANG Chuang;XIAO Yu;LIAN Rui;SONG Chun-li(Department of Cardiovascular Medicine,Second Hospital of Jilin University,Changehun 130012,China)
出处 《中国心血管病研究》 CAS 2019年第2期104-107,共4页 Chinese Journal of Cardiovascular Research
基金 吉林省教育厅十三五科学技术研究项目(JJKH20180104KJ) 吉林省财政厅卫生专项项目(2017年) 吉林省新型冠脉支架科技创新中心(JKFC2017250).
关键词 环状RNA 心血管衰老 心血管疾病 CircRNA Cardiovascular aging Cardiovascular disease
  • 相关文献

参考文献3

二级参考文献43

  • 1吕树铮.非ST段抬高急性冠脉综合征优化治疗策略[J].中国心血管病研究,2009,7(9):641-642. 被引量:7
  • 2Mozaffarian D, Benjamin EJ, Go AS, et al. Heart disease and stroke statistics-2015 Update. A report from the American Heart Association. Circulation, 2015,131:e329-332.
  • 3Ladue JS, Wroblewski F, Karmen A. Serum glutamic oxaloacetic transaminase activity in human acute transmural myocardial in-farction. Science, 1954,120:497-499.
  • 4Thygesen K, Mair J, Katus H, et al. Recommendations for the use of cardiac troponin measurement in acute cardac care. Eur Heart J, 2010,31:2197-2204.
  • 5Thygensen K, Mair J, Giannitsis E, et al. How to use high-sen-sitivity cardiac troponins in acute cardiac care. Eur Heart J, 2012,33:2252-2257.
  • 6Anderson JL, Adams CD, Antman EM, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/ non-ST-Elevation myocardial infarction:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines(Writing Committee to Revise the 2002 Guide-lines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Soci-ety of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. J Am Coil Cardiol,2007,50:e1-157.
  • 7Morrow DA, Cannon CP, Jesse RL, et al. National academy of clinical biochemistry laboratory medicine practice guidelines:clinical characteristics and utilization fo biochemical markers in acute coronary syndromes. Clin Chem, 2007,53:552-574.
  • 8Thygesen K, Alpert JS, Jaffe AS, et al. Joint ESC/ACCF/AHA/ WHF Task Force for the Universal Definition of Myocardial. Third universal definition of myocardial infarction. Eur Heart J, 2012,33:2551-2567.
  • 9Newby LK, Jesse RL, Babb JD, et al. ACCF 2012 expert consensus document on practical clinical considerations in the interpretation of troponin elevations:a report of the American College of Cardiology Foundation task force on Clinical Expert Consensus Documents. J Am Coll Cardiol, 2012,60:2427-2463.
  • 10Hamm CW, Bassand JP, Agewall S, et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation:The Task Force for the management of acute coronary syndromes(ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J, 2011,32:2999-3054.

共引文献16

同被引文献11

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部